Evidence map›Paper›PMID 29101229›Full record

ArticleThe Journal of biological chemistry2017

AlmG, responsible for polymyxin resistance in pandemic

Jeremy C Henderson, Carmen M Herrera, M Stephen Trent

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Public health aspects ofEFSA journal. European Food Safety Authority · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Detection ofMicroorganisms · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Genetic Manipulation of Wild Human GutJournal of bacteriology · 2020
    Article
  18. Review
  19. Loss of a Cardiolipin Synthase inJournal of bacteriology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

  • Commented on by
    2017
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeremy C HendersonFrom the Department of Infectious Diseases, Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602.
Carmen M HerreraFrom the Department of Infectious Diseases, Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602.
M Stephen TrentFrom the Department of Infectious Diseases, Center for Vaccines and Immunology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602 strent@uga.edu.
University of Georgia · US

Funding

The Outer Surface of Vibrio CholeraeR01AI076322 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI TRENT, MICHAEL STEPHEN · 2008 to 2017
$3.2M
NIAID NIH HHS R01 AI076322
6 · The paper itself

Abstract

Cationic antimicrobial peptides (CAMPs), such as polymyxins, are used as a last-line defense in treatment of many bacterial infections. However, some bacteria have developed resistance mechanisms to survive these compounds. Current pandemic O1

Indexed as

Drug Resistance, BacterialModels, MolecularAcyltransferasesAmino Acid SubstitutionAminoacyltransferasesAnti-Bacterial AgentsBacterial ProteinsCholeraGene DeletionGlycineHumansLipid ALipopolysaccharidesMolecular StructureMutationPandemicsAcyltransferasesAminoacyltransferasesAnti-Bacterial AgentsBacterial ProteinsGlycineLipid ALipopolysaccharidesphospholipid acyltransferasesPolymyxinsRecombinant Proteinsacyltransferaseaminoacyltransferaseantibiotic resistanceantimicrobial peptide (AMP)bacterial membranebacterial pathogenesisLABLATlipopolysaccharideLPLATVibrio cholera

Identifiers

PMID29101229
PMCPMC5743092
OpenAlexW2766082605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.